Fundraise / allotmentFiled on BSE ·

Bharat Parenterals Preferential Issue (1 Oct 2026)

Bharat Parenterals Limited seeks approval for Rs. 138,99,95,043.15 preferential issue

Bharat Parenterals · Pharmaceuticals & Biotechnology

Arthneeti Research DeskPublished 1 min read

Key highlights

  • Board approved on September 29, 2026, issuance of up to 9,12,759 equity shares at Rs. 1522.85 each via preferential issue
  • Investment in subsidiaries up to Rs. 135,00,00,000 and general corporate purposes up to Rs. 3,99,95,043.15, within 2 years of receipt of funds
  • EGM on October 23, 2026 at 11:30 a.m. through VC/OAVM; remote e-voting October 20-22, 2026

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Intimation For Extra-Ordinary General Meeting Of The Company To Be Held On Friday, October 23, 2026.

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Knowledge Marine

Engineering Services

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Bharat Parenterals

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.